164 related articles for article (PubMed ID: 25879885)
1. Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.
Seyfried F; von Rahden BH; Miras AD; Gasser M; Maeder U; Kunzmann V; Germer CT; Pelz J; Kerscher AG
BMC Cancer; 2015 Feb; 15():73. PubMed ID: 25879885
[TBL] [Abstract][Full Text] [Related]
2. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
4. Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades.
Kerscher AG; Chua TC; Gasser M; Maeder U; Kunzmann V; Isbert C; Germer CT; Pelz JO
Br J Cancer; 2013 Apr; 108(7):1432-9. PubMed ID: 23511564
[TBL] [Abstract][Full Text] [Related]
5. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
6. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
7. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer.
Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M
J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338
[TBL] [Abstract][Full Text] [Related]
9. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.
Thomassen I; van Gestel YR; van Ramshorst B; Luyer MD; Bosscha K; Nienhuijs SW; Lemmens VE; de Hingh IH
Int J Cancer; 2014 Feb; 134(3):622-8. PubMed ID: 23832847
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
15. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
16. A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis.
Okuno T; Yamaguchi H; Kitayama J; Ishigami H; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Kawai K; Kazama S; Ishihara S; Sunami E; Watanabe T
World J Surg Oncol; 2016 Apr; 14():107. PubMed ID: 27080037
[TBL] [Abstract][Full Text] [Related]
17. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis.
Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides GA; Fields RC; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
J Am Coll Surg; 2014 Oct; 219(4):664-75. PubMed ID: 25154671
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y
Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938
[TBL] [Abstract][Full Text] [Related]
19. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
[TBL] [Abstract][Full Text] [Related]
20. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
